Lupin to review US lawsuit accusing it of price fixing, customer allocation

15 May 2019 Evaluate

Lupin is reviewing the details of a lawsuit filed in a US court accusing 21 generic medicine producers of hatching a conspiracy to fix prices. The company has been a key pharmaceutical player in the US and has demonstrated full commitment to compliance with all laws and ethical business practices. 

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2113.40 -25.25 (-1.18%)
02-Feb-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.85
Dr. Reddys Lab 1190.50
Cipla 1309.40
Zydus Lifesciences 875.45
Lupin 2113.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×